2022 Infectious Disease: Pneumococcal Vaccine for Immunocompromised Patients [IFD22-1734]

2022 Infectious Disease: Pneumococcal Vaccine for Immunocompromised Patients [IFD22-1734]

December 20, 2021 December 31, 2022

Question Expiration Policy

Each question may be answered for 48 hours after the question is delivered

Overview

Immunocompromised patients are often not up to date with recommended vaccinations. Depending on the nature of their immunocompromising condition, this population may visit their sub-specialty physician more frequently than their primary care provider (PCP). Therefore, recent Infectious Diseases Society of America (IDSA) guidelines recommend that specialists and PCPs caring for immunocompromised populations share the responsibility of both a) vaccinating these patients, and b) recommending appropriate vaccinations for members of their households.

We aim to bridge the gap of vaccine compliance by improving specialists’ understanding of pneumococcal vaccination schedules through a CME Quiz-Time module, thus empowering clinicians to help ensure that their adult immunocompromised patients are appropriately vaccinated, decreasing the risk of invasive pneumococcal disease in this high-risk population.

This course, powered by QuizTime, consists of 13 questions delivered once per weekday so it will take approximately 3 weeks to complete. Each question allows for 1 reattempt if your first attempt is not correct, and each question expires 48 hours after it is sent. Before the conclusion of the course, you will receive an email containing any questions you have not attempted, and you will have 48 hours from the time the email is sent as a last chance for answering those questions. Upon completion of this course, you will receive a numeric credit code and instructions for texting that to our credit system to claim your credits.

Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vanderbilt University Medical Center designates this enduring material for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director: Don Moore, PhD

Course Item Writers: Sarah Homann, MD, MPH and Catherine Mannon, MD

Course Reviewers: Kim V. Garvey, MLIS, MS, PhD and Rob Bland, BA, MS

CME Activity Director: Bonnie Miller, MD, MMHC

CME Activity Coordinator: Emily Lagunas

Faculty indicated they have no financial relationships related to the content of this activity to disclose. 

Learning Objectives

  1. List indications and contraindications for receiving pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23)
  2. Compare and contrast PCV13 to PPSV23
  3. Create a PCV13 and PPSV23 vaccine schedule for a healthy individual
  4. Propose a PCV13 and PPSV23 vaccine schedule for an immunocompetent patient with chronic health problems
  5. Plan a PCV13 and PPSV23 vaccine schedule for an immunocompromised individual

Credit Information

  • AMA PRA Category 1 Credits™: 2.50 credits awarded for answering at least 10 questions .
  • Non-Physician Attendance: 2.50 credits awarded for answering at least 10 questions .